Animol Discovery

Discovery

Animol Discovery develops a biopharmaceutical platform for small-molecule drug discovery to provide medicines for companion and production animals.

Fauna Bio

This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners by analysing genetic data from disease-resistant animal species.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

adivo

This biotechnology company develops species-specific therapeutic monoclonal antibodies for companion animals, primarily targeting cancer and inflammatory diseases in dogs and cats.

Technology-enabled pharmaceutical company

This company develops small molecule drug candidates using artificial intelligence for the pharmaceutical and biotechnology industries.

Aviwell

This company develops microbiota-based feed solutions using an AI discovery platform to improve livestock growth and health for the agri-food industry.

MI:RNA

This company develops microRNA and artificial intelligence based diagnostic tests to detect diseases in companion and production animals for the veterinary and agricultural sectors.

Variartional

This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.